Meeder Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,547
| Closed | -$39K | – | 2527 |
|
|
2020
Q2 | $39K | Sell |
13,547
-6,215
| -31% | -$17.9K | ﹤0.01% | 978 |
|
|
2020
Q1 | $55K | Buy |
19,762
+867
| +5% | +$2.41K | ﹤0.01% | 883 |
|
|
2019
Q4 | $62K | Buy |
+18,895
| New | +$62K | ﹤0.01% | 962 |
|
|
2019
Q3 | – | Sell |
-27,671
| Closed | -$87K | – | 2371 |
|
|
2019
Q2 | $87K | Sell |
27,671
-4,082
| -13% | -$12.8K | 0.01% | 794 |
|
|
2019
Q1 | $117K | Sell |
31,753
-9,895
| -24% | -$36.5K | 0.01% | 660 |
|
|
2018
Q4 | $120K | Sell |
41,648
-15,702
| -27% | -$45.2K | 0.01% | 596 |
|
|
2018
Q3 | $151K | Buy |
57,350
+24,925
| +77% | +$65.6K | 0.01% | 551 |
|
|
2018
Q2 | $75.9K | Buy |
32,425
+22,579
| +229% | +$52.8K | 0.01% | 676 |
|
|
2018
Q1 | $28K | Buy |
9,846
+4,133
| +72% | +$11.8K | ﹤0.01% | 809 |
|
|
2017
Q4 | $16K | Buy |
5,713
+2,251
| +65% | +$6.3K | ﹤0.01% | 1013 |
|
|
2017
Q3 | $12K | Hold |
3,462
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q2 | $9K | Buy |
+3,462
| New | +$9K | ﹤0.01% | 1046 |
|
|
2016
Q3 | – | Sell |
-79,817
| Closed | -$251K | – | 1084 |
|
|
2016
Q2 | $251K | Hold |
79,817
| – | – | 0.02% | 543 |
|
|
2016
Q1 | $266K | Sell |
79,817
-40,821
| -34% | -$136K | 0.03% | 529 |
|
|
2015
Q4 | $427K | Buy |
120,638
+113,840
| +1,675% | +$403K | 0.04% | 381 |
|
|
2015
Q3 | $34K | Buy |
+6,798
| New | +$34K | ﹤0.01% | 630 |
|
|
2015
Q1 | – | Sell |
-44,045
| Closed | -$339K | – | 615 |
|
|
2014
Q4 | $339K | Buy |
+44,045
| New | +$339K | 0.04% | 356 |
|